Search results for "Pathologic"

showing 10 items of 710 documents

Advantages and Disadvantages of Bone Protective Agents in Metastatic Prostate Cancer: Lessons Learned

2016

Nine out of ten metastatic prostate cancer (PCa) patients will develop osseous metastases. Of these, every second will suffer from skeletal-related events (SRE). SRE are associated with an increased risk for death, which is markedly increased in the presence of pathological fracture. Moreover, health insurance costs nearly double in the presence of SRE. Zoledronic acid and denosumab are both approved drugs for the prevention or delay of SRE in castration-resistant prostate cancer (CRPC) patients with osseous metastases. However, long-term treatment with one of these two drugs is associated with the development of medication-related osteonecrosis of the jaw (MRONJ). Routine inspections of th…

Oncologymedicine.medical_specialtyReview03 medical and health sciencesProstate cancerzoledronic acid0302 clinical medicineInternal medicinemedicineStage (cooking)General DentistryPathologicalmedicine.diagnostic_testbusiness.industryIncidence (epidemiology)osteonecrosisdenosumab030206 dentistrymedicine.diseaseprostate cancerSurgerylcsh:RK1-715Zoledronic acidDenosumabBone scintigraphy030220 oncology & carcinogenesislcsh:DentistrybusinessOsteonecrosis of the jawmedicine.drugDentistry Journal
researchProduct

Osteonecrosis of the jaw in the era of targeted therapy and immunotherapy in oncology

2019

Osteonecrosis of the jaw (ONJ) is a well-known pathological condition in oncology derived from the use of bisphosphonates (BPs) and denosumab. Many molecular and immunological targets have been introduced for daily use in cancer treatment in recent years; consequently, new cases of ONJ have been reported in association with these drugs, especially if administered with BPs and denosumab. When the drugs are administered alone, ONJ is rarely seen. The objective of our study was to analyze the recent literature relative to the association of ONJ with these new drugs highlighting the pathogenic, clinical and therapeutic aspects. The close collaboration between maxillofacial surgeon, oncologist, …

Oncologymedicine.medical_specialtymedicine.medical_treatmentOdontologíaReview ArticleMaxilaresTargeted therapyOncologíaImmunomodulation03 medical and health sciences0302 clinical medicineInternal medicinemedicineOral manifestations030223 otorhinolaryngologyBonePathologicalbusiness.industryGénéralités030206 dentistryImmunotherapyCáncermedicine.diseaseCancer treatmentDenosumabSurgeryOral SurgeryOsteonecrosis of the jawbusinessAngiogenesis modulatorsInfectionmedicine.drug
researchProduct

[18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy

2007

To evaluate, in breast cancer patients treated by neoadjuvant chemotherapy, the predictive value of reduction in FDG uptake with regard to complete pathological response (pCR).Forty-seven women with non-metastatic, non-inflammatory, large or locally advanced breast cancer were included. Tumour uptake of FDG was evaluated before and after the first course of neoadjuvant chemotherapy. Four indices were used: maximal and average SUV without or with correction by body surface area and glycaemia (SUV(max), SUV(avg), SUV(max-BSA-G) and SUV(avg-BSA-G), respectively). The predictive value of reduction in FDG uptake with respect to pCR was studied by logistic regression analysis. Relationships betwe…

Oncologymedicine.medical_specialtymedicine.medical_treatmentPathological responseAntineoplastic AgentsBreast Neoplasms[SDV.IB.MN]Life Sciences [q-bio]/Bioengineering/Nuclear medicineSensitivity and Specificity030218 nuclear medicine & medical imaging18f fdg pet[SDV.IB.MN] Life Sciences [q-bio]/Bioengineering/Nuclear medicine[ SDV.IB.MN ] Life Sciences [q-bio]/Bioengineering/Nuclear medicine03 medical and health sciences0302 clinical medicineBreast cancerFluorodeoxyglucose F18Internal medicinemedicineHumansRadiology Nuclear Medicine and imagingNeoadjuvant therapyComputingMilieux_MISCELLANEOUSChemotherapymedicine.diagnostic_testbusiness.industryFdg uptakeReproducibility of ResultsGeneral MedicineMiddle Agedmedicine.diseasePrognosisNeoadjuvant Therapy3. Good healthClinical trialTreatment OutcomePositron emission tomography030220 oncology & carcinogenesisPositron-Emission TomographyFemaleRadiopharmaceuticalsbusiness
researchProduct

Expression of clec9a in the oral cancer microenvironment. A preliminary immunohistochemical pilot study

2021

Background The search for treatments to improve cancer survival has led to the emergence of immunotherapy and the study of the tumour microenvironment existing in neoplasms. This preliminary study aims to understand the clinical and pathological relationship of clec9a expression in oral cancer and to explore survival models for future studies. Material and methods: Immunohistochemical study that included 26 patients with a diagnosis of oral squamous cell carcinoma (OSCC) in mobile tongue and floor of the mouth. Clinical and histopathological variables were recorded, and the biomarkers clec9a for dendritic cells and CD8 and CD4 for lymphocytes were used. Results Clec9a was expressed in 58% o…

Oncologymedicine.medical_specialtymedicine.medical_treatmentPilot ProjectsInternal medicineOral Cancer and Potentially malignant disordersmedicineCarcinomaTumor MicroenvironmentHumansLectins C-TypepainGeneral DentistryPathologicalSurvival analysisUNESCO:CIENCIAS MÉDICASMouth neoplasmTumor microenvironmentbusiness.industryResearchquestionnaireCancerpsychometric validationImmunotherapymedicine.diseasePrognosisstomatognathic diseasesOtorhinolaryngologydisabilityHead and Neck NeoplasmsReceptors MitogenCarcinoma Squamous CellImmunohistochemistrySurgeryMouth Neoplasmshead and neck cancerbusiness
researchProduct

Angiogenesis of oral lichen planus: a possible pathogenetic mechanism.

2008

Objective: Oral Lichen Planus (OLP) is a chronic inflammatory disease with an autoimmune inflammatory pathogenesis. The aim of the research is to compare the vascular endothelial growth factor (VEGF) and adhesion of molecules in the biopsy samples of patients affected by OLP, in order to research the presence of the angiogenetic phenomenon and to understand its pathogenetic mechanism. Materials and Methods: Thirty OLP patients and thirty healthy subjects were enrolled in a study. The immunohistochemical analysis of the VEGF and vascularendothelial adhesion molecules was carried out by means of primary antibodies and anti-CD34, anti-VEGF, antiCD106 antigen (VCAM-1) and anti-CD54 antigen (ICA…

Oral Lichen Planus angiogenesis immunohistochemical VEGF VCAM-1 ICAM-1.MalePathologymedicine.medical_specialtyAngiogenesisCD34Neovascularizationchemistry.chemical_compoundAntigenstomatognathic systemSettore MED/28 - Malattie OdontostomatologicheBiopsyMedicineHumansGeneral Dentistrymedicine.diagnostic_testNeovascularization Pathologicbusiness.industryMiddle Agedmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Vascular endothelial growth factorstomatognathic diseasesOtorhinolaryngologychemistryUNESCO::CIENCIAS MÉDICASImmunohistochemistrySurgeryOral lichen planusFemalemedicine.symptombusinessLichen Planus OralMedicina oral, patologia oral y cirugia bucal
researchProduct

Painful scar neuropathy: principles of diagnosis and treatment

2015

Nerve-tissue interactions are critical. Peripheral nerve injuries may involve intraneural and extraneural scar formation and affect nerve gliding planes, sometimes leading to complex clinical presentations. All of these pathological entities involve pain as the main clinical symptom and can be subsumed under the term "painful scar neuropathy". The authors review the literature on treatment approaches to peripheral nerve scar neuropathy and the outcomes of neurolysis-associated procedures and propose a simple classification and a therapeutic approach to scar neuropathy. The search retrieved twenty-one papers, twenty of which reported pain reduction or resolution with various techniques. Ther…

Painful scarLesion typemedicine.medical_specialtybusiness.industrySettore MED/19 - Chirurgia PlasticaLogical approachExtraneuralComplex regional pain syndrome type II painful neuropathy painful scar neuropathy scar neuritis traction neuropathySurgeryTherapeutic approachPeripheral nerveNeuropathic painMedicinebusinessPathological
researchProduct

The role of combined techniques of scintigraphy and SPECT/CT in the diagnosis of primary hyperparathyroidism

2019

RATIONALE Primary hyperparathyroidism, usually as a result of a hyperfunctioning parathyroid gland, represents more than 90% cases of patients evaluated for hypercalcemia. Combined techniques of preoperative scintigraphy and SPECT/CT serve as a successful minimally-invasive parathyroidectomy. This recent imaging method provides four-dimensional functional images with advanced contrast resolution which greatly facilitates preoperative localization of parathyroid adenomas. PATIENT CONCERNS We presented the case of a male Caucasian patient, aged 67 years, who was investigated for hypercalcemia. Increased levels of parathormone, cervical ultrasonography without pathological changes, and negativ…

Parathyroidectomymedicine.medical_specialtymedicine.diagnostic_testbusiness.industrymedicine.medical_treatmentPlanar scintigraphyGeneral Medicinemedicine.diseaseScintigraphy03 medical and health sciences0302 clinical medicinemedicine.anatomical_structure030220 oncology & carcinogenesismedicineParathyroid gland030212 general & internal medicineRadiologyMedical diagnosisbusinessPathologicalPrimary hyperparathyroidismParathyroid adenomaMedicine
researchProduct

Pilot study on stress and resilience in families with premature newborns

2014

Introduction: Prematurity is associated with severe clinical conditions, long hospital stays, and uncertainty about patient outcomes. These circumstances lead to a stressful situation that may affect family functioning. The aim of this study was to study risk and protection factors affecting family functioning in preterm as compared to healthy term infants. Population and methods: Preterm infants with and without pathological conditions (n = 40) were recruited at 24 months post-conception age, together with a control group of healthy term newborn infants (n = 31). Parents or usual caregivers responded to the Inventory of Family Protection Factors and Parental Stress scales. The results were…

ParentsPediatricsmedicine.medical_specialtyFactores de protecciónmedia_common.quotation_subjectPopulationHospitalizaciónDysfunctional familyPilot ProjectsAffect (psychology)Protection factorsPediatricsRJ1-57003 medical and health sciences0302 clinical medicineReward030225 pediatricsManagement of Technology and InnovationAdaptation PsychologicalmedicineHumansFamilyParental stress030212 general & internal medicineRisk factoreducationPathologicalmedia_commoneducation.field_of_studyResiliencebusiness.industryInfant NewbornResilience PsychologicalPrematuridadHospitalizationCase-Control StudiesFamily resilienceResilienciaFamiliaPsychological resilienceAnalysis of varianceEstrés parentalbusinessPrematurityInfant PrematureStress Psychological
researchProduct

Psychological assessment in pathological gamblers treated with escitalopram

2013

Pathological Gambling (PG) is classified as a "Disorder of Impulse Control", but due to similarities with drug addiction is frequently described as a drug-free addiction (Potenza et al., 2012). PG is conceptualized as a behavioural addiction because of its neurobiologic, neurophysiologic and psychological features. Current therapeutical approaches seem unsatisfactory as they do not achieve definitive positive outcomes. Considering the well known psycopathological comorbidities, PG represents both a social (impact on relatives money/life) and a sanitary cost, in terms of pharmacological and psychological support. The compulsive behaviour detectable in PG, is a disease with neurophysiopatholo…

Pathological Gambling Behavioural addiction Escitalopram
researchProduct

La Psichiatria e l'Information and Communication Technology (ICT): le risorse e i rischi

2007

Pathological Internet Use technostress realtà virtuale
researchProduct